
Zvoľte si etiketu
zobrazené priamo na liekovkeReta + Cagri Blend
GLP-1
- Odosielame z Nemecka
Objednávka
- DHL so sledovaním zásielky
- Diskrétne balenie
V skratke
Reta + Cagri Blend v číslach
Kľúčové údaje z nášho lexikónu.
Celé heslo v lexikóne- Class
- Triple agonistGLP-1 / GIP / glucagon, + amylin analog
- Half-life
- Retatrutide around 6 dayscagrilintide around 7 to 8 days
- Form
- Lyophilisatepowder, reconstituted with BAC water
- Sizes
- 30 mg1 size in the shop
What studies show
All 5 sources in the lexicon- up to24.2 %Jastreboff et al., NEJM, 2023
- Sanyal et al., Nature Medicine, 2024
- Lau et al., The Lancet, 2021
Hodnotenia
Čo hovoria zákazníci
Len skutočné objednávky, ktoré obsahovali Reta + Cagri Blend.
Všetky hodnoteniaPre Reta + Cagri Blend zatiaľ neexistuje laboratórna analýza. Hlasujte za toDajte si to otestovať sami, polovicu zaplatímeVšetky laboratórne analýzy
Znalosti
Všetko o Reta + Cagri Blend
Podrobné informácie pripravujeme.
Dávkovanie
Načítavajú sa informácie o dávkovaní …
Hodí sa priobjednať
Čo k tomu potrebujete
Bakteriostatická voda sa do košíka pridá automaticky. Striekačky a tampóny jedným kliknutím.
Inzulínové striekačky
10 ks · 5.50 €
Alkoholové tampóny
50 ks · 10 €
Koľko vody?
Jednotky na striekačke pre vašu veľkosť liekovky.
Otvoriť kalkulačku →Is the Reta + Cagri Blend approved or studied?
No. As of 26 October 2026 the registry ClinicalTrials.gov lists no trial with Retatrutide and cagrilintide together. Both components are in phase 3 and not approved.
Why Retatrutide and cagrilintide together?
Both act on different satiety pathways: Retatrutide on GLP-1, GIP and glucagon, cagrilintide on amylin receptors. With semaglutide as the partner, weight loss in a phase 1b trial after 20 weeks was 17.1 instead of 9.8 percent. For Retatrutide as the partner there are no data.
What do the studies of the components show?
Retatrutide alone: in TRIUMPH-1 after 80 weeks 25.0 percent less body weight on average at the highest study dose, 3.9 percent on placebo. Cagrilintide alone: up to 10.8 percent after 26 weeks in phase 2, 3.0 percent on placebo. In a substudy liver fat also fell sharply on Retatrutide.
Why is the cagrilintide share so small?
The vial contains five times as much Retatrutide as cagrilintide, because Retatrutide is the stronger and limiting part. Anyone going by the Retatrutide share stays far below the amounts used in the cagrilintide trials. Whether the small share contributes anything has not been studied.
How long do the components stay in the body?
Retatrutide had a half-life of about six days in a phase 1b study, cagrilintide 159 to 195 hours in another study, so about a week. Both fit one dose per week.
Which side effects were seen with the components?
With both, mainly gastrointestinal effects such as nausea and diarrhoea, depending on the dose. On Retatrutide heart rate rose in a dose-dependent way in phase 2. Two satiety signals together may strengthen nausea at the start, this has not been measured for this blend.
Which trials are still running?
Nine phase 3 trials of Retatrutide are running, the largest on heart and kidney events until 2029. The RENEW trials of cagrilintide alone run until 2027. No trial of the blend is listed in the registry.
Súvisiace
Súvisiace produkty
Tirzepatide
Peptidy · GLP-1 a chudnutie GLP-1 a chudnutie
10 veľkosti
Laboratórne testované
= od 10 €/liekovka
Retatrutide
Peptidy · GLP-1 a chudnutie GLP-1 a chudnutie
11 veľkosti
Laboratórne testované
= od 16 €/liekovka
Semaglutide
Peptidy · GLP-1 a chudnutie GLP-1 a chudnutie
6 veľkosti
Laboratórne testované
= od 10 €/liekovka
Mazdutide
Peptidy · GLP-1 a chudnutie GLP-1 a chudnutie
2 veľkosti
= od 32 €/liekovka
Reta + Cagri Blend